Study Elesclomol Sodium in Patients With Relapsed or Refractory Acute Myeloid Leukemia

NCT01280786 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Elesclomol Sodium

Sponsor

Synta Pharmaceuticals Corp.